Cabugatan, Ayesha .
HRN: 23-84-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2023
CEFUROXIME 500MG (TAB)
10/07/2023
10/14/2023
PO
500 Mg
BID
S/p Episiorrhaphy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes